HypoglycemiaHyperglycemiaBlood GlucoseInsulinInsulin ComaDiabetic KetoacidosisHypoglycemic AgentsDiabetes Mellitus, Type 1Diabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Hemoglobin A, GlycosylatedDiabetes MellitusInsulin, Long-ActingInsulin Infusion SystemsIslets of LangerhansBlood Glucose Self-MonitoringGlucoseGlucagonHyperinsulinismInsulin, Regular, PorkInsulin LisproGliclazideDiabetic AngiopathiesDiabetic RetinopathyDiabetic NephropathiesInfusions, SubcutaneousCongenital HyperinsulinismSulfonylurea CompoundsGlucose Clamp TechniqueInsulin, IsophaneStreptozocinEpinephrineInsulin AntibodiesCritical IllnessPregnancy in DiabeticsPancreatic PolypeptideC-PeptideGlucose Tolerance TestAwarenessIslets of Langerhans TransplantationMetforminRisk FactorsTime FactorsComaDiabetes ComplicationsRetrospective StudiesClinical AlarmsRats, Sprague-DawleySeverity of Illness IndexTreatment OutcomeFastingGluconeogenesisVentromedial Hypothalamic NucleusDrug Administration ScheduleDiabetic FootInjections, SubcutaneousPostprandial PeriodInsulin-Secreting CellsBrain DiseasesSeizuresNesidioblastosisHydrocortisoneCognitionInsulinomaInsulin ResistanceBrainGlycosuriaPancreas, ArtificialGlipizideDiabetic ComaFatty Acids, NonesterifiedGlucokinaseIncidenceNorepinephrineLiverGlucagon-Like Peptide 1HomeostasisRats, Wistar3-Hydroxybutyric AcidReference ValuesBody WeightPancreasFollow-Up StudiesProspective StudiesDiazoxidePhlorhizinInsulin AspartPancreatectomyDipeptidyl-Peptidase IV InhibitorsDiabetic CardiomyopathiesGermanyInfusions, IntravenousMonitoring, AmbulatoryDiabetic DietDisease Models, AnimalCognition DisordersLactic AcidGlucagon-Secreting CellsLactatesMice, Inbred C57BL